Mortality rates for pediatric rheumatology patients are lower than earlier data indicated, a study showed. Researchers said one possible reason for increased survival could be improved treatments introduced in the 1990s. The study also found predictors of mortality include rheumatic diagnoses, age at diagnosis, sex, and early use of systemic steroids and methotrexate.

Related Summaries